ÖZET
Spondiloartritler (SpA), güncel klinik sınıflamalara göre periferik ve aksiyal ağırlıklı olarak değerlendirilmektedir. Aksiyal SpA (axSpA) tanımı temel olarak enflamatuvar bel ağrısına ek olarak görüntüleme bulguları (direkt grafi veya manyetik rezonans) veya ilişkili klinik bulguları içermektedir. Hastalık seyrinde progresyonun en önemli belirleyicisi yeni kemik oluşumudur ve tedavide ana hedeflerden biri yeni kemik oluşumunun engellenmesidir. Bu sayede önemli bir morbidite kaynağı kontrol edilmiş olacaktır. Günümüzde yeni kemik oluşumunun değerlendirildiği standart yöntem direkt grafilerdir. Sakroiliak eklem grafisi özellikle tanı ve sınıflandırmada büyük öneme sahipken progresyon için önemi sınırlıdır. Spinal grafiler hastalık progresyonun takibinde kullanılmaktadır. Tanımlanmış lezyonlardan oluşan çeşitli skorlar aracılığı ile takipler yapılmaktadır. Bu derlemede axSpA seyrinin ve progresyonunun değerlendirilmesi için kullanılan görüntüleme yöntemleri ve skorlama sistemleri gözden geçirilecektir. Kullanılmakta olan yöntemlerin hastalık takibine olan katkılarının yanı sıra kısıtlılıklarına da değinilecektir.
References
1Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
2Rudwaleit M, van der Heijde D, Landewe R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
3Poddubnyy D, Sieper J. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 2014;26:377-83.
4Maksymowych WP, Salonen D, Inman RD, Rahman P, Lambert RG. Low-dose infliximab (3 mg/kg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a randomized placebo-controlled study. J Rheumatol 2010;37:1728-34.
5Pedersen SJ, Maksymowych WP. Recent Advances in Imaging of the Axial Skeleton in Spondyloarthritis for Diagnosis, Assessment of Treatment Effect, and Prognostication. Curr Rheumatol Rep 2015;17:60.
6Maksymowych WP. Imaging in Axial Spondyloarthritis: Evaluation of Inflammatory and Structural Changes. Rheum Dis Clin North Am 2016;42:645-62.
7Bazzocchi A, Aparisi Gomez MP, Guglielmi G. Conventional Radiology in Spondyloarthritis. Radiol Clin North Am 2017;55:943-66.
8van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
9Wanders AJ, Landewe RB, Spoorenberg A, et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004;50:2622-32.
10Christiansen AA, Hendricks O, Kuettel D, et al. Limited Reliability of Radiographic Assessment of Sacroiliac Joints in Patients with Suspected Early Spondyloarthritis. J Rheumatol 2016;44:70-7.
11Xia Q, Fan D, Yang X, et al. Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e5960.
12Poddubnyy D, Rudwaleit M, Haibel H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011;70:1369-74.
13Protopopov M, Poddubnyy D. Radiographic progression in non-radiographic axial spondyloarthritis. Expert Rev Clin Immunol 2018;14:525-33.
14Sepriano A, Ramiro S, Landewe R, Dougados M, van der Heijde D. Percentage of progressors in imaging: can we ignore regressors? RMD Open 2019;5:e000848.
15Aydin SZ, Maksymowych WP, Bennett AN, McGonagle D, Emery P, Marzo-Ortega H. Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis 2011;71:56-60.
16Akar S, Isik S, Birlik B, et al. Baseline sacroiliac joint magnetic resonance imaging abnormalities and male sex predict the development of radiographic sacroiliitis. Clin Rheumatol 2013;32:1511-7.
17Wang R, Gabriel SE, Ward MM. Progression of Nonradiographic Axial Spondyloarthritis to Ankylosing Spondylitis: A Population-Based Cohort Study. Arthritis Rheumatol 2016;68:1415-21.
18Dougados M, Demattei C, van den Berg R, et al. Rate and Predisposing Factors for Sacroiliac Joint Radiographic Progression After a Two-Year Follow-up Period in Recent-Onset Spondyloarthritis. Arthritis Rheumatol 2016;68:1904-13.
19Sany J, Rosenberg F, Panis G, Serre H. Unclassified HLA-B27 inflammatory rheumatic diseases: follow up of 23 patients. Arthritis Rheum 1980;23:258-59.
20Schattenkirchner M, Kruger K. Natural course and prognosis of HLA-B27-positive oligoarthritis. Clin Rheumatol 1987;6 Suppl 2:83-6.
21Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988;15:1109-14.
22Oostveen J, Prevo R, den Boer J, van da Laar, M. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 1999;26:1953-58.
23Kumar A, Bansal M, Srivastava DN, et al. Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Int 2001;20:221-4.
24Sampaio-Barros PD, Bertolo MB, Kraemer MH, Marques- Neto JF, Samara AM. Undifferentiated spondyloarthropathies: a 2-year follow-up study. Clin Rheumatol 2001;20:201-6.
25Huerta-Sil G, Casasola-Vargas JC, Londono JD, et al. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis 2006;65:642-6.
26Bennett AN, McGonagle D, O’Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008;58:3413-8.
27Sampaio-Barros PD, Bortoluzzo AB, Conde RA, Costallat LTL, Samara AM, Bertolo MB. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010;37:1195-9.
28Backland G, Alsing R, Singh K, Nossent JC. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27. Arthritis Care Res (Hoboken) 2013;65:448-53.
29Ruderman E, Strand V, Joshi A, et al. Spondyloarthritis Epidemiology and Burden Phase 2 [SPEED 2] Study: Disease Progression In Axial Spondyloarthropathy (SpA). Arthritis Rheum 2013;65(Suppl 10):S1052-3.
30Sepriano A, Rudwaleit M, Sieper J, van den Berg, Landewe R, van der Heijde D. Five-year follow-up of radiographic sacroiliitis: progression as well as improvement? Ann Rheum Dis 2016;75:1262-3.
31Dougados M, Sepriano A, Molto A, et al. Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort. Ann Rheum Dis 2017;76:1823-8.
32Constantino F, Zeboulon N, Said-Nahal R, Breben M. Radiographic sacroiliitis develops predictably over time in a cohort of familial spondyloarthritis followed longitudinally. Rheumatology (Oxford) 2017;56:811-7.
33MacKay K, Mack C, Brophy S, Calin A. The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 1998;41:2263-70.
34MacKay K, Brophy S, Mack C, Doran M, Calin A. The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol 2000;27:2866-72.
35Taylor HG, Wardle T, Beswick EJ, Dawes PT. The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol 1991;30:330-5.
36Creemers MC, Franssen MJ, van’t Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-9.
37Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change. Arthritis Rheum 2009;61:764-71.
38Ramiro S, van Tubergen A, Stolwijk C, Landewe R, van de Bosch F, Dougados M, et al. Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)? Arthritis Res Ther 2013;15:R14.
39Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005;64:179-82.
40Mandl P, Navarro-Compan V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 2015;74:1327-39.
41Baraliakos X, Listing J, Rudwaleit M, et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 2007;66:910-5.
42Brophy S, Mackay K, Al-Saidi A, Taylor G, Calin A. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002;29:1236-43.
43Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis 2013;74:52-9.
44Ramiro S, van der Heijde D, van Tubergen A, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 2014;73:1455-61.
45van Tubergen A, Ramiro S, van der Heijde D, Dougados M, Mielants H, Landewe R. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study. Ann Rheum Dis 2011;71:518-23.
46Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012;64:1388-98.
47Poddubnyy D, Protopopov M, Haibel H, Braun J, Rudwaleit M, Sieper J. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Ann Rheum Dis 2016;75:2114-8.
48Ramiro S, van der Heijde D, Sepriano A, et al. Spinal radiographic progression in early axial Spondyloarthritis: Five-year results from the DESIR cohort. Arthritis Care Res (Hoboken) 2019;71:1678-84.
49Claudepierre P, de Hooge MS, Feydy A, et al. Reliability of mSASSS scoring in everyday practice in DESIR-cohort study centres: cross-sectional study of agreement with trained readers. Ann Rheum Dis 2018;75:2213-4.
50Poddubnyy D, Listing J, Haibel H, Knuppel S, Rudwaleit M, Sieper J. Functional relevance of radiographic spinal progression in axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Rheumatology (Oxford) 2018;57:703-11.
